CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function
Authors
Beerendonk CCM
Berger C
+42 more
Bresters D
Broer L
Brooke RJ
Byrne J
Chemaitilly W
Clemens E
de Vries ACH
Dirksen U
Falck Winther J
Fossa SD
Grabow D
Haupt R
Hudson MM
Kaatsch P
Kaiser M
Kaspers GL
Kepak T
Kremer LC
Krijthe JH
Kruseova J
Lambalk CB
Laven JSE
Loonen JJ
Modan-Moses D
Mvan Dulmen-den Broeder E
Overbeek A
Pluijm SMF
Robison LL
Ronckers CR
Spix C
Tissing WJ
Uitterlinden AG
van den Berg MH
van den Heuvel-Eibrink M
van der Heiden-van der Loo M
van der Kooi ALF
van der Pal HJ
van Dijk M
van Leeuwen FE
Versluys B
Yasui Y
Zolk O
Publication date
15 September 2021
Publisher
Bioscientifica
Doi
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1530%2Fey.18.9.8
Last time updated on 03/03/2025